The office of MedPacto, Inc. was relocated to new place with its research center.
Sep 15, 2016EVENTSHit 193
MedPacto, Inc. has been relocated to new building as follows address,
|Previous||The MedPacto Inc. board has appointed Dr. Seong-Jin Kim as a co-chief executive officer|
|Next||MedPacto Announces Clinical Collaboration with MSD to Evaluate Vactosertib, an Investigational TGF-β Type I Receptor Inhibitor, in combination with KEYTRUDA® (pembrolizumab)|